Characterization of Inter-Alpha-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Expression, a Prostate Basal Cell Marker.
The prostate epithelium contains secretory luminal epithelial cells, basal epithelial cells and neuroendocrine cells. Luminal cells are secretory cells that produce prostatic secretions and basal cells are involved in regeneration and maintenance of epithelial tissue. The absence of a basal cell layer is a defining morphological feature of prostate adenocarcinoma. Immunohistochemical detection of basal cells using standard markers such as p63 and high molecular weight keratin (34βE12) is routinely employed to differentiate invasive carcinoma from benign architecture mimics. Additional protein like TRIM29 and ETS2 are also known to stain prostatic basal cells. While recent advances in sequencing and proteomic technologies helped identify many luminal epithelial markers for prostate cancers, basal cells are less investigated. In the current study, we identified Inter-Alpha-Trypsin Inhibitor Heavy Chain 5 (ITIH5) as a gene expressed exclusively in the basal cells of prostate epithelium. ITIH5 is a hyaluronan-stabilizing extracellular matrix protein that has been shown to be downregulated by promoter DNA hypermethylation in various cancers. Gene expression analysis using published dataset suggested ITIH5 is expressed in prostate basal cells compared to luminal cells. To characterize the potential diagnostic utility of ITIH5 in prostatic tissues, we evaluated its immunohistochemical expression profile across benign and malignant prostatic glands. Our immunohistochemistry analysis confirmed that ITIH5 protein is mainly in the cytoplasmic compartment of basal cells lining benign prostatic acini while prostate luminal cells showed no signal for ITIH5. Importantly, the cytoplasmic staining of ITIH5 reflected the nuclear staining of p63 in terms of cell they are staining, a well-established prostate basal cell marker that is a nuclear protein. Our results suggest ITIH5 serves as a novel basal cell marker for prostate tissue differential diagnosis on its own or in combination with other established markers. Biological role and significance of ITIH5 expression in prostate basal cells need to be elucidated.
Authors
- Upender Manne (ORCID: https://orcid.org/0000-0002-1545-3032)
- Nallasivam Palanisamy (ORCID: https://orcid.org/0000-0002-0633-9772)
- Edgar Dahl (ORCID: https://orcid.org/0000-0002-8439-7994)
- Sofía Cañete‐Portillo (ORCID: https://orcid.org/0000-0003-4206-2296)
- Darshan Shimoga Chandrashekar (ORCID: https://orcid.org/0000-0002-4295-9127)
- George Jabboure Netto (ORCID: https://orcid.org/0000-0003-3915-9134)
- Sooryanarayana Varambally (ORCID: https://orcid.org/0000-0002-2277-1127)
- Farrukh Afaq (ORCID: https://orcid.org/0000-0001-8612-0879)
- Gopal Kumar
- Shannon L. Carskadon (ORCID: https://orcid.org/0000-0002-6950-0308)
Institutions
- Henry Ford Health System (US)
- Vanderbilt University (US)
- University of Alabama at Birmingham (US)
- University of Pennsylvania (US)
- RWTH Aachen University (DE)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.13.766426
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- preprint
Funders
- RWTH Aachen University